Abstract
Background According to World Health Organization (WHO), United Arab Emirates (UAE) has one of the highest prevalence rates of obesity in the Middle East at 34%. There is a paralleled rise in the incidence of related metabolic conditions, particularly type 2 diabetes, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Body mass index (BMI) alone is an insufficient marker of abdominal adiposity and addition of waist circumference (WC) can help to assess the cardiometabolic risk.
Aim To study the prevalence of obesity related diseases in a multidisciplinary weight management program and determine the relationship to obesity anthropometric indices.
Methods This is a cross-sectional study conducted at Mediclinic Parkview Hospital in Dubai, UAE. 308 patients have been evaluated from January 2019 until September 2019 as part of a multi-disciplinary weight management program. Key demographics, anthropometrics, and clinical data was analyzed using Statistical Package for Social Sciences software version 25 (SPSS Inc., Chicago, IL).
Results Three hundred and eight patients taking part in the weight management program were studied. The population was constituted of 103 (33%) males and 205 (67%) females. The mean age was 41 years (±9.6) with a median BMI of 34.5 (±6.7) and 33.7 (±7.8) for males and females respectively. Mean waist circumference was 113.4 cm (±23.3) and 103.5 cm (±16.2), fat percent was 33.7% (±11.6) and 45 (±6.8), fat mass was 41 kg (±15.2) and 41.1 (±14.1), and visceral fat was 6.5 kg (±3.2) and 3.1 (±1.8), for males and females respectively. The population was heterogeneous with 38 nationalities. BMI strongly correlated with waist circumference (male; female, r=0.67; r=0.72) and visceral fat (male; female, r=0.89; r=0.78). Further, waist circumference was significantly associated with risk of diabetes, hypertension, and NAFLD.
Conclusion The study has confirmed the high prevalence rates of obesity related diseases in a private hospital setting in a multinational cohort of obese patients. BMI and waist circumference are the most representative measures of obesity in our population and correlate with abdominal adiposity and obesity related diseases. Further studies will play a part in assessing the benefit of these measures during weight reduction interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NA
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approvals were taken from local Mediclinic Institutional Research Board; and Dubai Scientific Research Ethics Committee, Dubai Health Authority, Dubai, UAE.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available on request
Abbreviations
- (BMI)
- Body mass index
- (WC)
- Waist circumference
- (HC)
- Hip circumference
- (WHR)
- Waist hip ratio
- (NAFLD)
- Non-alcoholic fatty liver disease
